Fritextsökning
Innehållstyper
-
Swedish Healthtech Company 1928 Pushing Forward
The full service analytics platform is expanding the business.
-
It´s time to establish relations
Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.
-
Läkemedlet som fördröjer diabetesdebut
Ett läkemedel som riktar sig mot immunsystemet har visat sig kunna fördröja insjuknandet i typ 1-diabetes. ”Ett steg närmare vårt ultimata mål: en framtid utan typ 1-diabetes.”
-
Helena Strigård: The rise of the community
Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.
-
Pharma Outsourcing igång på Stockholm Waterfront
-
Column: "Are we already living in the new normal?"
2020 felt like the year that we were building the house around us whilst moving into it at the same time.
-
CDC varnar för stigmatisering vid postcovid
Den amerikanska smittskyddsmyndigheten, CDC, uppmanar läkare att ha ett empatiskt förhållningssätt vid behandling av patienter med postcovid.
-
The perfect formula for decision-making
No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.
-
Coordination of world-class research facilities
Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...
-
Filter tips for safer pipetting and better accuracy
Biohit has launched new Safetyspace Filter Tips that have more space between the sample and the filter than conventional filter tips usually have.
-
Meet the governmental life science office
More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...
-
The best wealth is Health
We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...
-
Relax at the After Fair
Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen a...
-
Forskare undersökte syrapumpshämmare med datorsimuleringar – gör koppling till demens
Forskare från Karolinska institutet har i en preklinisk studie sett en mekanism som de anser pekar på att långvarig användning av syradämpande läkemedel kan bid...
-
Giulia Gaudenzi: ”Key lessons from global health research”
The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Brexit creeping closer – or?
In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.
-
They’re all doing it – buying drug research
It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.
-
Första resultaten för nygammalt läkemedel mot covid-19
I en ny studie förbättrades tillståndet för 68 procent av patienter med allvarlig covid-19 när de fick läkemedlet remdesivir. Men studien har flera svagheter oc...
-
Pilots want to live too
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Opinion: Where do all the cool Swedish life science companies go?
It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...
-
Odlingsmedium för inducerade pluripotenta celler
Cellartis DEF-CS Xeno Free från Takara Clontech är ett robust odlingsmedium.